| Ms Leisha A Mahoney, CNM | |
|
1600 Haddon Ave, Camden, NJ 08103-3101 | |
| (856) 757-3500 | |
| Not Available |
| Full Name | Ms Leisha A Mahoney |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 8 Years |
| Location | 1600 Haddon Ave, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205378452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 25ME00060701 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
BioAmber, Inc. has been awarded a 2011 Presidential Green Chemistry Challenge Award, presented by the Environmental Protection Agency (EPA) and the American Chemical Society (ACS). The Award promotes technology that provides substantial environmental benefits using green chemistry. BioAmber's platform was recognized as the leading technology in the field of succinic acid.
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research.
The Griffith University project will develop and pilot a model of clinical education for health students that improves their learning experience and better reflects the realities of clinical practice.
The international community has been struggling to predict and contain successive waves of the COVID-19 pandemic, caused by the novel SARS-CoV-2 pathogen. The degree of success has varied between countries. In Taiwan, the use of contact tracing, with testing and isolation of confirmed cases, promises to end the ongoing third wave of the illness within two months. The strategy employed is described in a new preprint available on the medRxiv* server.
› Verified 3 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
BioAmber, Inc. has been awarded a 2011 Presidential Green Chemistry Challenge Award, presented by the Environmental Protection Agency (EPA) and the American Chemical Society (ACS). The Award promotes technology that provides substantial environmental benefits using green chemistry. BioAmber's platform was recognized as the leading technology in the field of succinic acid.
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research.
The Griffith University project will develop and pilot a model of clinical education for health students that improves their learning experience and better reflects the realities of clinical practice.
The international community has been struggling to predict and contain successive waves of the COVID-19 pandemic, caused by the novel SARS-CoV-2 pathogen. The degree of success has varied between countries. In Taiwan, the use of contact tracing, with testing and isolation of confirmed cases, promises to end the ongoing third wave of the illness within two months. The strategy employed is described in a new preprint available on the medRxiv* server.
› Verified 3 days ago
| Entity Name | Camcare Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790857696 PECOS PAC ID: 2567365117 Enrollment ID: O20040130000243 |
News Archive
BioAmber, Inc. has been awarded a 2011 Presidential Green Chemistry Challenge Award, presented by the Environmental Protection Agency (EPA) and the American Chemical Society (ACS). The Award promotes technology that provides substantial environmental benefits using green chemistry. BioAmber's platform was recognized as the leading technology in the field of succinic acid.
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research.
The Griffith University project will develop and pilot a model of clinical education for health students that improves their learning experience and better reflects the realities of clinical practice.
The international community has been struggling to predict and contain successive waves of the COVID-19 pandemic, caused by the novel SARS-CoV-2 pathogen. The degree of success has varied between countries. In Taiwan, the use of contact tracing, with testing and isolation of confirmed cases, promises to end the ongoing third wave of the illness within two months. The strategy employed is described in a new preprint available on the medRxiv* server.
› Verified 3 days ago
| Entity Name | Meridian Medical Group-specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942362587 PECOS PAC ID: 6507962206 Enrollment ID: O20070425000673 |
News Archive
BioAmber, Inc. has been awarded a 2011 Presidential Green Chemistry Challenge Award, presented by the Environmental Protection Agency (EPA) and the American Chemical Society (ACS). The Award promotes technology that provides substantial environmental benefits using green chemistry. BioAmber's platform was recognized as the leading technology in the field of succinic acid.
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research.
The Griffith University project will develop and pilot a model of clinical education for health students that improves their learning experience and better reflects the realities of clinical practice.
The international community has been struggling to predict and contain successive waves of the COVID-19 pandemic, caused by the novel SARS-CoV-2 pathogen. The degree of success has varied between countries. In Taiwan, the use of contact tracing, with testing and isolation of confirmed cases, promises to end the ongoing third wave of the illness within two months. The strategy employed is described in a new preprint available on the medRxiv* server.
› Verified 3 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
BioAmber, Inc. has been awarded a 2011 Presidential Green Chemistry Challenge Award, presented by the Environmental Protection Agency (EPA) and the American Chemical Society (ACS). The Award promotes technology that provides substantial environmental benefits using green chemistry. BioAmber's platform was recognized as the leading technology in the field of succinic acid.
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research.
The Griffith University project will develop and pilot a model of clinical education for health students that improves their learning experience and better reflects the realities of clinical practice.
The international community has been struggling to predict and contain successive waves of the COVID-19 pandemic, caused by the novel SARS-CoV-2 pathogen. The degree of success has varied between countries. In Taiwan, the use of contact tracing, with testing and isolation of confirmed cases, promises to end the ongoing third wave of the illness within two months. The strategy employed is described in a new preprint available on the medRxiv* server.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Leisha A Mahoney, CNM 43 Main St Ste 1a, Avon By The Sea, NJ 07717-1000 Ph: (732) 776-9790 | Ms Leisha A Mahoney, CNM 1600 Haddon Ave, Camden, NJ 08103-3101 Ph: (856) 757-3500 |
News Archive
BioAmber, Inc. has been awarded a 2011 Presidential Green Chemistry Challenge Award, presented by the Environmental Protection Agency (EPA) and the American Chemical Society (ACS). The Award promotes technology that provides substantial environmental benefits using green chemistry. BioAmber's platform was recognized as the leading technology in the field of succinic acid.
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research.
The Griffith University project will develop and pilot a model of clinical education for health students that improves their learning experience and better reflects the realities of clinical practice.
The international community has been struggling to predict and contain successive waves of the COVID-19 pandemic, caused by the novel SARS-CoV-2 pathogen. The degree of success has varied between countries. In Taiwan, the use of contact tracing, with testing and isolation of confirmed cases, promises to end the ongoing third wave of the illness within two months. The strategy employed is described in a new preprint available on the medRxiv* server.
› Verified 3 days ago
Dorothy Dara Cam, CNM, WHNP-BC Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1000 Atlantic Ave Ste 170, Camden, NJ 08104 Phone: 856-341-8474 | |
Victoria Clark, MSN, CNM, WHNP-BC Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3500 | |
Jessica Gale Schwarz, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1600 Haddon Ave Fl 3, Camden, NJ 08103 Phone: 856-757-3500 Fax: 856-365-4088 | |
Mrs. Tobi Faith Smolensky, CNM, APN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Ms. Colleen Elizabeth Riley, MSN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3500 Fax: 856-365-4088 | |
Ms. Adetutu Mojisola Sandra Ogunleye, CRNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 519-525 West Street, Camden, NJ 08103 Phone: 856-968-2320 Fax: 856-968-2317 |